dr. plimack on the challenges with available immunotherapies for bladder cancer
Published 6 years ago • 99 plays • Length 0:47Download video MP4
Download video MP3
Similar videos
-
1:00
dr. plimack on the growth of immunotherapy in bladder cancer
-
1:04
dr. plimack on immunotherapy combinations in bladder cancer
-
1:35
dr. plimack on choosing a checkpoint inhibitor in bladder cancer
-
1:13
dr. bellmunt on challenges with immunotherapy in bladder cancer
-
0:49
dr. elizabeth plimack on immunotherapy potential in bladder cancer
-
1:18
dr. plimack on combo of pembrolizumab/epacodostat in bladder cancer
-
1:14
dr. plimack on second-line checkpoint inhibitors in bladder cancer
-
1:44
dr. plimack on a phase ib study of pembrolizumab in bladder cancer
-
1:33
dr. gupta on challenges with perioperative immunotherapy in bladder cancers
-
0:53
dr. plimack on strategies for developing cure for locally advanced urothelial carcinoma
-
0:55
dr. plimack on frontline checkpoint inhibitors in bladder cancer
-
0:51
dr. elizabeth plimack on ipilimumab and pd-l1 inhibitors in the treatment of bladder cancer
-
1:25
progress and challenges of immunotherapy for bladder cancer
-
1:18
dr. plimack on keynote-045 trial for pembrolizumab in urothelial carcinoma
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
1:39
dr. elizabeth plimack on nivolumab in kidney cancer
-
3:52
expert comment: the javelin bladder 100 study | elizabeth plimack
-
1:26
dr. sklar on challenges with clinical trials in bladder cancer
-
1:05
dr. sonpavde on the biggest challenges in bladder cancer